Market research
RH7.F Ryman Healthcare Limited
F EUR Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 965M
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- Not available
- Beta
- 0.34
Community
Investor discussion
1 comment
Sign in to join the RH7.F discussion.
5 years, 5 months ago
Ryman Healthcare Limited is currently in a long term downtrend where the price is trading 8.8% below its 200 day moving average.
From a valuation standpoint, the stock is 98.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 17.9.
Finally, its free cash flow fell by 112.8% to $-16M since the same quarter in the previous year.
Based on the above factors, Ryman Healthcare Limited gets an overall score of 1/5.